抗迁移与常规全覆膜金属支架治疗恶性远端胆道梗阻的单中心长期比较
研究回顾性比较抗迁移鳍状全覆膜金属支架(AMS)与常规喇叭口全覆膜金属支架(CS)治疗不可切除恶性远端胆道梗阻的迁移与复发性胆道梗阻风险。
要点
- 两组复发性胆道梗阻风险相似。
核心结论
- 抗迁移FCSEMS粗迁移率低于常规FCSEMS且通畅性(RBO风险)相似,但校正分析未达统计学显著。
研究设计与样本
- 单中心回顾性队列研究,纳入2020年4月至2024年接受ERCP置入AMS或CS的不可切除dMBO成人患者,共276例(CS 172例,AMS 104例)。
- 采用逆概率治疗加权Cox模型分析时间-事件结局,并以倾向性评分匹配进行敏感性分析。
主要发现
- 两组RBO风险相似。
临床怎么用
- 抗迁移FCSEMS可能降低dMBO患者支架迁移,但需权衡校正后无显著差异及RBO风险相似。
局限性
- 单中心回顾性设计,样本量有限,校正后迁移差异未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Fully covered self-expandable metal stents (FCSEMSs) palliate distal malignant biliary obstruction (dMBO), but migration remains a limitation. We compared an antimigration stent (AMS) using finned FCSEMSs with a convention stent (CS) using flared FCSEMSs. METHODS: A retrospective cohort (April 2020-2024) of adults with unresectable dMBO undergoing ERCP with AMS or CS was analyzed. Primary outcomes were stent migration and recurrent biliary obstruction (RBO). Time-to-event outcomes were analyzed using inverse probability of treatment weighting (IPTW) Cox models, with propensity score matching (PSM) for sensitivity. RESULTS: Among 276 patients (CS, 172; AMS, 104), crude migration was lower with AMS (0.96% vs 7.6%; P = .02). After IPTW adjustment, migration risk remained directionally lower but was not statistically significant (hazard ratio, 0.23; 95% CI, 0.03-1.80; P = .16). Migration remained numerically lower after PSM (P = .10). RBO risk was similar between groups. CONCLUSIONS: Antimigration FCSEMSs demonstrated lower crude migration with similar patency (RBO risk), but adjusted analyses did not reach statistical significance.
引用
- Palomera-Tejeda E, Ayoub F, Keihanian T, et al. Comparison of antimigration versus conventional fully covered self-expandable metal stents for malignant distal biliary obstruction: a single-center long-term study. Gastrointest Endosc. 2026. PMID: 41672107. doi:10.1016/j.gie.2026.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。